Lumican: a new inhibitor of matrix metalloproteinase-14 activity (Q24305431)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25304424%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

title

Lumican: a new inhibitor of matrix metalloproteinase-14 activity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25304424%20AND%20SRC:MED&resulttype=core&format=json

Katarzyna Pietraszek-Gremplewicz

21 February 2020

author

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25304424%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

François-Xavier Maquart

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25304424%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

Aurore Chatron-Colliet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25304424%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Stéphane Brézillon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25304424%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Corinne Perreau

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25304424%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Anna Jakubiak-Augustyn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25304424%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Hubert Krotkiewski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25304424%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Yanusz Wegrowski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25304424%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

language of work or name

English

0 references

publication date

7 October 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25304424%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25304424%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

588

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25304424%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25304424%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

4319-4324

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25304424%20AND%20SRC:MED&resulttype=core&format=json

Role of the small leucine-rich proteoglycan (SLRP) family in pathological lesions and cancer cell growth

21 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

Primary structure of human lumican (keratan sulfate proteoglycan) and localization of the gene (LUM) to chromosome 12q21.3-q22

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

Lumcorin: a leucine-rich repeat 9-derived peptide from human lumican inhibiting melanoma cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine‐rich proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

The small leucine-rich proteoglycan lumican inhibits melanoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

Negative regulation of transforming growth factor-beta by the proteoglycan decorin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

Decorin and chondroitin-6 sulfate inhibit B16V melanoma cell migration and invasion by cellular acidification

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

Matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

Roles of membrane-type matrix metalloproteinase-1 in tumor invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

Matrix metalloproteinases and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

MT1-MMP-mediated cleavage of decorin in corneal angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

Cleavage of lumican by membrane-type matrix metalloproteinase-1 abrogates this proteoglycan-mediated suppression of tumor cell colony formation in soft agar

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

Matrix metalloproteinase expression by endothelial cells in collagen lattices changes during co-culture with fibroblasts and upon induction of decorin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1α, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

Effect of lumican on the migration of human mesenchymal stem cells and endothelial progenitor cells: involvement of matrix metalloproteinase-14

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

Monitoring and Inhibiting MT1-MMP during Cancer Initiation and Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

Lumican inhibits cell migration through α2β1 integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

The Chromatographic Separation and Amino Acid Composition of the Subunits of Several Collagens*

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

Novel selective MMP-13 inhibitors reduce collagen degradation in bovine articular and human osteoarthritis cartilage explants

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

The intrinsic protein flexibility of endogenous protease inhibitor TIMP-1 controls its binding interface and affects its function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

Lumican - derived peptides inhibit melanoma cell growth and migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

More than matrix: the multifaceted role of decorin in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

Site-selective chemical protein glycosylation protects from autolysis and proteolytic degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

Lumican inhibits angiogenesis by interfering with α2β1 receptor activity and downregulating MMP-14 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

7 January 2021

Cell surface activation of progelatinase A (proMMP-2) and cell migration

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

7 January 2021

Homologous sequence in lumican and fibromodulin leucine-rich repeat 5-7 competes for collagen binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

7 January 2021

Membrane-type matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.09.040

7 January 2021

10.1016/J.FEBSLET.2014.09.040

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25304424%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25304424%20AND%20SRC:MED&resulttype=core&format=json